View in EDS

Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis.

Saved in:
Bibliographic Details
Title: Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis.
Authors: Le Teuff G; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Oncostat U1018 INSERM, labeled Ligue Contre le Cancer, Université Paris-Saclay, Villejuif, France. Gwenael.LETEUFF@gustaveroussy.fr., Cozic N; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Oncostat U1018 INSERM, labeled Ligue Contre le Cancer, Université Paris-Saclay, Villejuif, France., Boyer JC; Service de Biochimie et Biologie Moléculaire, CHU Carémeau, Nîmes, France., Boige V; Department of cancer medicine, Gustave-Roussy Cancer Campus, Paris-Saclay and Paris-Sud Universities, Villejuif, France.; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Equipe Labellisée Ligue Nationale Contre le Cancer, CNRS SNC, 5096, Paris, France., Diasio RB; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Cancer Center, Rochester, MN, USA., Taieb J; Université Paris-Cité, SIRIC CARPEM, Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, AP-HP, Paris, France., Meulendijks D; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Palles C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Schwab M; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; Departments of Clinical Pharmacology, and of Biochemistry and Pharmacy, University of Tuebingen, Tuebingen, Germany.; Cluster of Excellence IFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, 72074, Tübingen, Germany., Deenen M; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, the Netherlands., Largiadèr CR; Department of Clinical Chemistry, Bern University Hospital, University of Bern, Inselspital, Bern, Switzerland., Marinaki A; Purine Research Laboratory, St Thomas' Hospital, London, UK., Jennings BA; Norwich Medical School, University of East Anglia, Norwich, UK., Wettergren Y; Sahlgrenska University Hospital, Goteborg, Sweden., Di Paolo A; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Gross E; LMU Munich, University Hospital, Campus Grosshadern, Munich, Germany., Budai B; National Institute of Oncology, Budapest, Hungary., Ackland SP; College of Heath, Medicine and Wellbeing, University of Newcastle, Newcastle, NSW, Australia., van Kuilenburg ABP; Amsterdam UMC, location University of Amsterdam, Laboratory Genetic Metabolic Diseases, Meibergdreef 9, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Imaging and biomarkers, Amsterdam, The Netherlands., McLeod HL; Intermountain Precision Genomics, Intermountain Healthcare, St George, UT, USA., Milano G; Oncopharmacology Laboratory, Centre Antoine Lacassagne, Nice, France., Thomas F; Institut Claudius Regaud, IUCT-Oncopôle and CRCT, University of Toulouse, Inserm, Toulouse, France., Loriot MA; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Equipe Labellisée Ligue Nationale Contre le Cancer, CNRS SNC, 5096, Paris, France.; Hôpital Européen Georges Pompidou, Hôpitaux Universitaires Paris Ouest, Paris, France., Kerr D; Nuffield Division of Clinical and Laboratory Sciences and University of Oxford, Oxford, UK., Schellens JHM; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Laurent-Puig P; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Equipe Labellisée Ligue Nationale Contre le Cancer, CNRS SNC, 5096, Paris, France.; Hôpital Européen Georges Pompidou, Hôpitaux Universitaires Paris Ouest, Paris, France., Shi Q; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Pignon JP; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Oncostat U1018 INSERM, labeled Ligue Contre le Cancer, Université Paris-Saclay, Villejuif, France., Etienne-Grimaldi MC; Oncopharmacology Laboratory, Centre Antoine Lacassagne, Nice, France.
Corporate Authors: FUSAFE collaborative group
Source: British journal of cancer [Br J Cancer] 2024 Mar; Vol. 130 (5), pp. 808-818. Date of Electronic Publication: 2024 Jan 15.
Publication Type: Meta-Analysis; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38225422
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Le+Teuff+G%22">Le Teuff G</searchLink>; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Oncostat U1018 INSERM, labeled Ligue Contre le Cancer, Université Paris-Saclay, Villejuif, France. Gwenael.LETEUFF@gustaveroussy.fr.<br /><searchLink fieldCode="AU" term="%22Cozic+N%22">Cozic N</searchLink>; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Oncostat U1018 INSERM, labeled Ligue Contre le Cancer, Université Paris-Saclay, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Boyer+JC%22">Boyer JC</searchLink>; Service de Biochimie et Biologie Moléculaire, CHU Carémeau, Nîmes, France.<br /><searchLink fieldCode="AU" term="%22Boige+V%22">Boige V</searchLink>; Department of cancer medicine, Gustave-Roussy Cancer Campus, Paris-Saclay and Paris-Sud Universities, Villejuif, France.; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Equipe Labellisée Ligue Nationale Contre le Cancer, CNRS SNC, 5096, Paris, France.<br /><searchLink fieldCode="AU" term="%22Diasio+RB%22">Diasio RB</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Cancer Center, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Taieb+J%22">Taieb J</searchLink>; Université Paris-Cité, SIRIC CARPEM, Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, AP-HP, Paris, France.<br /><searchLink fieldCode="AU" term="%22Meulendijks+D%22">Meulendijks D</searchLink>; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Palles+C%22">Palles C</searchLink>; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Schwab+M%22">Schwab M</searchLink>; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; Departments of Clinical Pharmacology, and of Biochemistry and Pharmacy, University of Tuebingen, Tuebingen, Germany.; Cluster of Excellence IFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, 72074, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Deenen+M%22">Deenen M</searchLink>; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Largiadèr+CR%22">Largiadèr CR</searchLink>; Department of Clinical Chemistry, Bern University Hospital, University of Bern, Inselspital, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Marinaki+A%22">Marinaki A</searchLink>; Purine Research Laboratory, St Thomas' Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Jennings+BA%22">Jennings BA</searchLink>; Norwich Medical School, University of East Anglia, Norwich, UK.<br /><searchLink fieldCode="AU" term="%22Wettergren+Y%22">Wettergren Y</searchLink>; Sahlgrenska University Hospital, Goteborg, Sweden.<br /><searchLink fieldCode="AU" term="%22Di+Paolo+A%22">Di Paolo A</searchLink>; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.<br /><searchLink fieldCode="AU" term="%22Gross+E%22">Gross E</searchLink>; LMU Munich, University Hospital, Campus Grosshadern, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Budai+B%22">Budai B</searchLink>; National Institute of Oncology, Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Ackland+SP%22">Ackland SP</searchLink>; College of Heath, Medicine and Wellbeing, University of Newcastle, Newcastle, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22van+Kuilenburg+ABP%22">van Kuilenburg ABP</searchLink>; Amsterdam UMC, location University of Amsterdam, Laboratory Genetic Metabolic Diseases, Meibergdreef 9, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Imaging and biomarkers, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22McLeod+HL%22">McLeod HL</searchLink>; Intermountain Precision Genomics, Intermountain Healthcare, St George, UT, USA.<br /><searchLink fieldCode="AU" term="%22Milano+G%22">Milano G</searchLink>; Oncopharmacology Laboratory, Centre Antoine Lacassagne, Nice, France.<br /><searchLink fieldCode="AU" term="%22Thomas+F%22">Thomas F</searchLink>; Institut Claudius Regaud, IUCT-Oncopôle and CRCT, University of Toulouse, Inserm, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Loriot+MA%22">Loriot MA</searchLink>; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Equipe Labellisée Ligue Nationale Contre le Cancer, CNRS SNC, 5096, Paris, France.; Hôpital Européen Georges Pompidou, Hôpitaux Universitaires Paris Ouest, Paris, France.<br /><searchLink fieldCode="AU" term="%22Kerr+D%22">Kerr D</searchLink>; Nuffield Division of Clinical and Laboratory Sciences and University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Schellens+JHM%22">Schellens JHM</searchLink>; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Laurent-Puig+P%22">Laurent-Puig P</searchLink>; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Equipe Labellisée Ligue Nationale Contre le Cancer, CNRS SNC, 5096, Paris, France.; Hôpital Européen Georges Pompidou, Hôpitaux Universitaires Paris Ouest, Paris, France.<br /><searchLink fieldCode="AU" term="%22Shi+Q%22">Shi Q</searchLink>; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Pignon+JP%22">Pignon JP</searchLink>; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Oncostat U1018 INSERM, labeled Ligue Contre le Cancer, Université Paris-Saclay, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Etienne-Grimaldi+MC%22">Etienne-Grimaldi MC</searchLink>; Oncopharmacology Laboratory, Centre Antoine Lacassagne, Nice, France.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22FUSAFE+collaborative+group%22">FUSAFE collaborative group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220370635%22">British journal of cancer</searchLink> [Br J Cancer] 2024 Mar; Vol. 130 (5), pp. 808-818. <i>Date of Electronic Publication: </i>2024 Jan 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Meta-Analysis; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+on+behalf+of+Cancer+Research+UK%22">Nature Publishing Group on behalf of Cancer Research UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0370635 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-1827 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070920%22">00070920 </searchLink><i>NLM ISO Abbreviation: </i>Br J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38225422
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41416-023-02517-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 808
    Titles:
      – TitleFull: Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Le Teuff G
      – PersonEntity:
          Name:
            NameFull: Cozic N
      – PersonEntity:
          Name:
            NameFull: Boyer JC
      – PersonEntity:
          Name:
            NameFull: Boige V
      – PersonEntity:
          Name:
            NameFull: Diasio RB
      – PersonEntity:
          Name:
            NameFull: Taieb J
      – PersonEntity:
          Name:
            NameFull: Meulendijks D
      – PersonEntity:
          Name:
            NameFull: Palles C
      – PersonEntity:
          Name:
            NameFull: Schwab M
      – PersonEntity:
          Name:
            NameFull: Deenen M
      – PersonEntity:
          Name:
            NameFull: Largiadèr CR
      – PersonEntity:
          Name:
            NameFull: Marinaki A
      – PersonEntity:
          Name:
            NameFull: Jennings BA
      – PersonEntity:
          Name:
            NameFull: Wettergren Y
      – PersonEntity:
          Name:
            NameFull: Di Paolo A
      – PersonEntity:
          Name:
            NameFull: Gross E
      – PersonEntity:
          Name:
            NameFull: Budai B
      – PersonEntity:
          Name:
            NameFull: Ackland SP
      – PersonEntity:
          Name:
            NameFull: van Kuilenburg ABP
      – PersonEntity:
          Name:
            NameFull: McLeod HL
      – PersonEntity:
          Name:
            NameFull: Milano G
      – PersonEntity:
          Name:
            NameFull: Thomas F
      – PersonEntity:
          Name:
            NameFull: Loriot MA
      – PersonEntity:
          Name:
            NameFull: Kerr D
      – PersonEntity:
          Name:
            NameFull: Schellens JHM
      – PersonEntity:
          Name:
            NameFull: Laurent-Puig P
      – PersonEntity:
          Name:
            NameFull: Shi Q
      – PersonEntity:
          Name:
            NameFull: Pignon JP
      – PersonEntity:
          Name:
            NameFull: Etienne-Grimaldi MC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2024 Mar
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1532-1827
          Numbering:
            – Type: volume
              Value: 130
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: British journal of cancer
              Type: main
ResultId 1